Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Quest Pharmatech Inc
V.QPT
Alternate Symbol(s):
QPTFF
Healthcare
Biotechnology
Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest...
Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:QPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
(16)
•••
TrickyGame
X
View Profile
View Bullboard History
Post by
TrickyGame
on Jan 24, 2024 11:40am
Why did the Study fail?
I thought the trial was going very wel? Wasn't oregovomab going to be the new Standard of Care for Ovarian Cancer? seems kind of sus to recommend stopping the trial but also recomend following up
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 23, 2024 5:50pm
New Press Release - Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits
EDMONTON, AB, Jan. 23, 2024 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced that it has received information that the...
read article.
New PEA Indicates an Ultra Low-Cost Uranium Project with Huge Exploration Upside
posted Apr 26, 2024 9:00am by
Blue Sky Uranium Corp
-
|
This PEA reaffirms that the deposit is a leading low-cost uranium-vanadium project. We believe that this resurgent uranium market has a strong long-term outlook and we are therefore preparing to complete a prefeasibility study as soon as possible ...read more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 23, 2024 11:16am
RE:RE:RE:Interesting
Date Time Price Size Conditions Buyer ID Seller ID JAN 23 10:56:44 AM 0.03 198,000 7 7 JAN 23 10:56:44 AM 0.03 2,000 7 7 JAN 23 09:30:00 AM 0.04 2,000 7 1 Same games. QPT now has a $6.7M
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 17, 2024 11:10am
RE:RE:Interesting
Date Time Price Size Conditions Buyer ID Seller ID JAN 17 10:35:13 AM 0.04 100,000 7 1 JAN 17 10:31:02 AM 0.04 5,000 79 1 JAN 17 10:31:02 AM 0.04 89,000 80 1 JAN 17 10:31:02 AM 0.04 1,000 19 1
...more
(118)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 16, 2024 11:19am
RE:Interesting
Shenzhen Hepalink owns approximately 15% of QPT and was not enough to keep Shawn Lu as a director. Strange!! Well just bought some at the new 52-week low. G1945V
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Jan 16, 2024 11:02am
Interesting
JAN 16 10:32:57 AM 0.045 50,000 9 1 JAN 16 10:03:33 AM 0.045 1,000 62 1 JAN 16 10:00:50 AM 0.045 15,000 1 1 JAN 16 10:00:50 AM 0.05 844 NBDLT 19 62 JAN 16 10:00:50 AM 0.05 15,000 7 1 1 is
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 16, 2024 10:49am
RE:RE:RE:RE:RE:RE:RE:Interesting
Yeah, trying to figure out how he did not get elected. How else can it be? Trying to figure this out.
(118)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 16, 2024 10:28am
RE:RE:RE:RE:RE:RE:Interesting
I was more interested in how the information came about, concerning the group of large shareholders, not meeting the 10% insider threshold, that joined together, to vote against him and that there
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 16, 2024 10:16am
RE:RE:RE:RE:RE:Interesting
The Shawn Lu information comes from QPT's release. https://ceo.ca/@newswire/quest-pharmatech-announces-results-from-agm-6dbe0 Still don't understand how that happened so just trying to
...more
(118)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 16, 2024 9:37am
RE:RE:RE:RE:Interesting
ARIMA11, how did you obtain this information on Shawn Lu, if you don't mind sharing? The reason for asking is that Shawn Lu is also a director of Resverlogix Inc (RVX) put there by Shenzhen
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 15, 2024 9:09pm
RE:RE:RE:Interesting
One possible way Shawn Lu was not re-elected was that a group of large shareholders not meeting the 10% insiders threshold joined together to vote against him. Shenzhen Hepalink Pharmaceutical
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 15, 2024 8:32pm
RE:RE:Interesting
"Close to getting our ducks in a row for Phase III or an acquisition...." This was three months ago...
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 15, 2024 8:28pm
RE:Interesting
https://www.youtube.com/watch?v=-WD4tVbzSZI (see 10;19)
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Jan 15, 2024 8:26pm
Interesting
https://www.google.com/search?q=jeffrey+shon&sourceid=chrome&ie=UTF-8#fpstate=ive&ip=1&vld=cid:14339779,vid:-WD4tVbzSZI,st:0 (see 10;19)
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 15, 2024 11:13am
RE:RE:Interesting
Thanks for asking. Its incredibly frustrating and feels hopeless at times. Still can't believe QPT has not received anything but paper that seems to be totally worthless. Yes, the deal has gotten
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale